Skip to main content

MoneyWorks4Me

Merck Board to consider interim dividend

10 Jan 2014 Evaluate

Merck has informed that a meeting of the Board of Directors of the Company will be held on January 31, 2014 to consider and approve the Audited Financial Results for the quarter & year ended December 31, 2013 and to consider recommendation of dividend for the year 2013.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..